Catherine J. Wu, MD

Cancer vaccines are a “cross-cutting approach” that may be applicable across several cancer types, according to Catherine J. Wu, MD.

mRNA may be a potential modality for developing cancer-based vaccines, according to Catherine J. Wu, MD.

Analyzing the KRAS mutation across various cancer types may be a worthwhile target when using a cancer vaccine or immunotherapy, says Catherine J. Wu, MD.